These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16317865)

  • 1. Is banning direct to consumer advertising of prescription medicine justified paternalism?
    Lau Y
    J Bioeth Inq; 2005; 2(2):69-74. PubMed ID: 16317865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit?
    Toop L; Richards D; Saunders B
    N Z Med J; 2003 Aug; 116(1180):U556; discussion U556. PubMed ID: 14581976
    [No Abstract]   [Full Text] [Related]  

  • 3. Banning all drug promotion is the best option pending major reforms.
    Mansfield PR
    J Bioeth Inq; 2005; 2(2):75-81. PubMed ID: 16317866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
    Schwartz MI
    Food Drug Law J; 2008; 63(1):1-33. PubMed ID: 18561453
    [No Abstract]   [Full Text] [Related]  

  • 5. Striving for quality use of medicines: how effective is Australia's ban on direct-to-consumer prescription medicine advertising?
    Brown S
    J Law Med; 2009 Feb; 16(4):666-83. PubMed ID: 19297873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DTCA of prescription medicines in the European Union: is there still a need for a ban?
    Poser M
    Eur J Health Law; 2010 Dec; 17(5):471-84. PubMed ID: 21133243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we be concerned about direct-to-consumer advertising of prescription drugs?
    Jordens C; Anderson L
    J Bioeth Inq; 2005; 2(2):61-2. PubMed ID: 16317863
    [No Abstract]   [Full Text] [Related]  

  • 8. Physicians' negative views of direct-to-consumer advertising (DTCA): the international evidence grows.
    Toop L; Richards D
    N Z Med J; 2004 Jun; 117(1195):U905. PubMed ID: 15282619
    [No Abstract]   [Full Text] [Related]  

  • 9. Paternalistic or protective? Freedom of expression and direct-to-consumer drug advertising policy in Canada.
    Gold JL
    Health Law Rev; 2003; 11(2):30-6. PubMed ID: 15706698
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct-to-consumer advertising--where does the public interest lie?
    Saunders B
    N Z Med J; 2003 Aug; 116(1180):U557; discussion U557. PubMed ID: 14581978
    [No Abstract]   [Full Text] [Related]  

  • 11. The ethical implications of direct-to-consumer pharmaceutical advertising.
    Farrell JM
    Philos Public Policy Q; 2003; 23(3):20-3. PubMed ID: 15282933
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct-to-consumer advertising of prescription drugs.
    Frosch DL; Grande D
    LDI Issue Brief; 2010; 15(3):1-4. PubMed ID: 20469541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
    Berndt ER
    N Engl J Med; 2005 Jan; 352(4):325-8. PubMed ID: 15673797
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
    Javitt GH; Stanley E; Hudson K
    Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug risks and free speech--can Congress ban consumer drug ads?
    Shuchman M
    N Engl J Med; 2007 May; 356(22):2236-9. PubMed ID: 17476002
    [No Abstract]   [Full Text] [Related]  

  • 16. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
    Mintzes B; Barer M; Lexchin J; Bassett KL
    Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct-to-consumer advertising of prescription medication in New Zealand.
    Every-Palmer S; Duggal R; Menkes DB
    N Z Med J; 2014 Aug; 127(1401):102-10. PubMed ID: 25225761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.
    Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA
    CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct-to-consumer-advertising of prescription medicines: a theoretical approach to understanding.
    Harker M; Harker D
    Leadersh Health Serv (Bradf Engl); 2007; 20(2):76-84. PubMed ID: 20690467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consumers' knowledge, perceptions, and responsiveness to direct-to-consumer advertising of prescription medicines.
    Hoek J; Maubach N
    N Z Med J; 2007 Feb; 120(1249):U2425. PubMed ID: 17308562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.